Increased secretion of CCL2 in CAAs has been observed in mouse BC models and BC patients [59], and it promotes BC metastasis by promoting angiogenesis and EMT via activation of the STAT3 signaling pathway [60]. The gene discussed is CCL2; the disease is breast cancer.